Stock Scorecard
Stock Summary for Encompass Health Corp (EHC) - $107.09 as of 12/23/2025 3:00:34 PM EST
Total Score
9 out of 30
Safety Score
48 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EHC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EHC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EHC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EHC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EHC (48 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Financial Details for EHC
Company Overview |
|
|---|---|
| Ticker | EHC |
| Company Name | Encompass Health Corp |
| Country | N/A |
| Description | Encompass Health Corporation (EHC) is a leading provider of integrated in-home and post-acute healthcare services across the United States, headquartered in Birmingham, Alabama. The company operates a robust network of inpatient rehabilitation hospitals and home health agencies, positioning itself as a vital player in the transforming healthcare landscape. With a strong focus on delivering exceptional, patient-centered care and improving patient outcomes through innovative solutions, Encompass Health is well-positioned for growth and continues to present a compelling investment opportunity amidst ongoing healthcare sector dynamics. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/5/2026 |
Stock Price History |
|
| Last Day Price | 107.09 |
| Price 4 Years Ago | 50.55 |
| Last Day Price Updated | 12/23/2025 3:00:34 PM EST |
| Last Day Volume | 989,316 |
| Average Daily Volume | 887,901 |
| 52-Week High | 127.99 |
| 52-Week Low | 87.45 |
| Last Price to 52 Week Low | 22.46% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 18.14 |
| Sector PE | 135.38 |
| 5-Year Average PE | 19.94 |
| Free Cash Flow Ratio | 223.10 |
| Industry Free Cash Flow Ratio | 68.07 |
| Sector Free Cash Flow Ratio | 32.38 |
| Current Ratio Most Recent Quarter | 1.14 |
| Total Cash Per Share | 0.48 |
| Book Value Per Share Most Recent Quarter | 23.57 |
| Price to Book Ratio | 4.61 |
| Industry Price to Book Ratio | 28.09 |
| Sector Price to Book Ratio | 56.98 |
| Price to Sales Ratio Twelve Trailing Months | 1.87 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.01 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.53 |
| Analyst Buy Ratings | 11 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 100,616,000 |
| Market Capitalization | 10,774,967,440 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 1/2/2026 |
| Previous Dividend Amount | 0.1900 |
| Current Dividend Amount | 0.1900 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.70 |
| Trailing Annual Dividend Yield | 0.66% |
| Forward Annual Dividend Rate | 0.76 |
| Forward Annual Dividend Yield | 0.71% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 26.67% |
| 3-Year Dividend Growth Rate Percentage | 12.55% |
| 5-Year Dividend Growth Rate Percentage | -9.24% |
| All-Time Dividend Growth Rate Percentage | -1.08% |
| Dividend Payout Ratio | 13.18% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 16.70% |
| Annual Earnings Growth | 29.46% |
| Reported EPS 12 Trailing Months | 5.31 |
| Reported EPS Past Year | 4.00 |
| Reported EPS Prior Year | 4.43 |
| Net Income Twelve Trailing Months | 541,000,000 |
| Net Income Past Year | 455,700,000 |
| Net Income Prior Year | 352,000,000 |
| Quarterly Revenue Growth YOY | 9.40% |
| 5-Year Revenue Growth | 3.13% |
| Operating Margin Twelve Trailing Months | 16.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 48,700,000 |
| Total Cash Past Year | 85,400,000 |
| Total Cash Prior Year | 104,200,000 |
| Net Cash Position Most Recent Quarter | -2,345,200,000 |
| Net Cash Position Past Year | -2,273,800,000 |
| Long Term Debt Past Year | 2,359,200,000 |
| Long Term Debt Prior Year | 2,687,800,000 |
| Total Debt Most Recent Quarter | 2,393,900,000 |
| Equity to Debt Ratio Past Year | 0.47 |
| Equity to Debt Ratio Most Recent Quarter | 0.50 |
| Total Stockholder Equity Past Year | 2,067,000,000 |
| Total Stockholder Equity Prior Year | 1,647,500,000 |
| Total Stockholder Equity Most Recent Quarter | 2,373,800,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 402,600,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.00 |
| Free Cash Flow Past Year | 360,300,000 |
| Free Cash Flow Prior Year | 267,700,000 |
Options |
|
| Put/Call Ratio | 0.25 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.58 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 12/22/2025 10:02:49 PM EST |